Literature DB >> 15207699

Structure-function analysis of human protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1, POMGnT1.

Keiko Akasaka-Manya1, Hiroshi Manya, Kazuhiro Kobayashi, Tatsushi Toda, Tamao Endo.   

Abstract

Protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) catalyzes the transfer of GlcNAc to O-mannose of glycoproteins. Mutations in the POMGnT1 gene cause a type of congenital muscular dystrophy called muscle-eye-brain disease (MEB). We evaluated several truncated mutants of POMGnT1 to determine the minimal catalytic domain. Deletions of 298 amino acids in the N-terminus and 9 amino acids in the C-terminus did not affect POMGnT1 activity, while larger deletions on either end abolished activity. These data indicate that the minimal catalytic domain is at least 353 amino acids. Single amino acid substitutions in the stem domain of POMGnT1 from MEB patients abolished the activity of the membrane-bound form but not the soluble form. This suggests that the stem domain of the soluble form of POMGnT1 is unnecessary for activity, but that some amino acids play a crucial role in the membrane-bound form.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207699     DOI: 10.1016/j.bbrc.2004.05.129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa.

Authors:  Mingchu Xu; Takeyuki Yamada; Zixi Sun; Aiden Eblimit; Irma Lopez; Feng Wang; Hiroshi Manya; Shan Xu; Li Zhao; Yumei Li; Adva Kimchi; Dror Sharon; Ruifang Sui; Tamao Endo; Robert K Koenekoop; Rui Chen
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

Review 2.  Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.

Authors:  Naosuke Nakamura; Dmitry Lyalin; Vladislav M Panin
Journal:  Semin Cell Dev Biol       Date:  2010-04-01       Impact factor: 7.727

3.  Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.

Authors:  Naoyuki Kuwabara; Hiroshi Manya; Takeyuki Yamada; Hiroaki Tateno; Motoi Kanagawa; Kazuhiro Kobayashi; Keiko Akasaka-Manya; Yuriko Hirose; Mamoru Mizuno; Mitsunori Ikeguchi; Tatsushi Toda; Jun Hirabayashi; Toshiya Senda; Tamao Endo; Ryuichi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-04       Impact factor: 11.205

Review 4.  Muscular dystrophies due to glycosylation defects.

Authors:  Francesco Muntoni; Silvia Torelli; Martin Brockington
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

5.  Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.

Authors:  Ute Hehr; Goekhan Uyanik; Claudia Gross; Maggie C Walter; Axel Bohring; Monika Cohen; Barbara Oehl-Jaschkowitz; Lynne M Bird; Ghiat M Shamdeen; Ulrich Bogdahn; Gerhard Schuierer; Haluk Topaloglu; Ludwig Aigner; Hanns Lochmüller; Jürgen Winkler
Journal:  Neurogenetics       Date:  2007-09-29       Impact factor: 2.660

Review 6.  Muscular dystrophies due to defective glycosylation of dystroglycan.

Authors:  F Muntoni; M Brockington; C Godfrey; M Ackroyd; S Robb; A Manzur; M Kinali; E Mercuri; M Kaluarachchi; L Feng; C Jimenez-Mallebrera; E Clement; S Torelli; C A Sewry; S C Brown
Journal:  Acta Myol       Date:  2007-12

7.  Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease.

Authors:  S Saredi; A Ardissone; A Ruggieri; E Mottarelli; L Farina; R Rinaldi; E Silvestri; C Gandioli; S D'Arrigo; F Salerno; L Morandi; P Grammatico; C Pantaleoni; I Moroni; M Mora
Journal:  J Neurol Sci       Date:  2012-05-02       Impact factor: 3.181

8.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

9.  The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies.

Authors:  Alexander Peter Murphy; Volker Straub
Journal:  J Neuromuscul Dis       Date:  2015-07-22

10.  Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing.

Authors:  Xiaona Fu; Haipo Yang; Hui Jiao; Shuo Wang; Aijie Liu; Xiaoqing Li; Jiangxi Xiao; Yanling Yang; Xiru Wu; Hui Xiong
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.